Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shil Patel

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Nuclear Medicine and Biology|June 28, 2022
In vivo tracking of [<sup>89</sup>Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administrationShil Patel, Karl F Schmidt, Mohammed Farhoud, et al.
Synapse (New York, N.Y.)|August 12, 2009
Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18Terence G Hamill, Nagaaki Sato, Makoto Jitsuoka, et al.
Molecular Imaging and Biology|November 16, 2019
Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse IntegrityShil Patel, Ashley Knight, Stephen Krause, et al.
Science Advances|February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activitySushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Synapse (New York, N.Y.)|June 5, 2010
Synthesis, characterization, and monkey PET studies of [¹⁸F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435Eric D Hostetler, Waisi Eng, Aniket D Joshi, et al.
Synapse (New York, N.Y.)|August 6, 2010
The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracersTerence G Hamill, Waisi Eng, Andrew Jennings, et al.
Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.
Science Immunology|November 10, 2023
Zfp281 and Zfp148 control CD4<sup>+</sup> T cell thymic development and T<sub>H</sub>2 functionsLaura B Chopp, Xiaoliang Zhu, Yayi Gao, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Tissue Engineering. Part A|September 28, 2018
Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell PhenotypeLindsey T Saldin, Shil Patel, Li Zhang, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Nuclear Medicine and Biology|June 28, 2022
In vivo tracking of [<sup>89</sup>Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administrationShil Patel, Karl F Schmidt, Mohammed Farhoud, et al.
Synapse (New York, N.Y.)|August 12, 2009
Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18Terence G Hamill, Nagaaki Sato, Makoto Jitsuoka, et al.
Molecular Imaging and Biology|November 16, 2019
Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse IntegrityShil Patel, Ashley Knight, Stephen Krause, et al.
Science Advances|February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activitySushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Synapse (New York, N.Y.)|June 5, 2010
Synthesis, characterization, and monkey PET studies of [¹⁸F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435Eric D Hostetler, Waisi Eng, Aniket D Joshi, et al.
Synapse (New York, N.Y.)|August 6, 2010
The synthesis and preclinical evaluation in rhesus monkey of [¹⁸F]MK-6577 and [¹¹C]CMPyPB glycine transporter 1 positron emission tomography radiotracersTerence G Hamill, Waisi Eng, Andrew Jennings, et al.
Pharmacology Research & Perspectives|March 30, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonistRachel Garner, Shobha Gopalakrishnan, John A McCauley, et al.
Science Immunology|November 10, 2023
Zfp281 and Zfp148 control CD4<sup>+</sup> T cell thymic development and T<sub>H</sub>2 functionsLaura B Chopp, Xiaoliang Zhu, Yayi Gao, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Tissue Engineering. Part A|September 28, 2018
Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell PhenotypeLindsey T Saldin, Shil Patel, Li Zhang, et al.
Pageof 4